Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Obsessive - Compulsive Disorder: early-phase trial registry
30 of 86 indexed Obsessive - Compulsive Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #160 of 28,707 conditions by registered trial count.
86 US clinical trials · 30 currently recruiting · #160 of 28,707 conditions by registered trial count
Obsessive - Compulsive Disorder: 86 US clinical trials tracked, 30 recruiting.
Obsessive - Compulsive Disorder is the subject of 86 registered US clinical trials on ClinicalTrials.gov, 30 of them currently open to new participants. 10 are in Phase 3-4 (later-stage) and 19 in Phase 1-2 (earlier-stage). The most active sponsor is Baylor College of Medicine, running 7 of these trials.
Enrollment posture brief
Registry condition obsessive-compulsive-disorder
OPEN 30 | RECR 35% | LATE 10 | EARLY 19 | RANK #160 | SPON 7
Volume-matched condition peers
Nearest open-share peer: Hemophilia A (35% recruiting · 43 trials)
Obsessive - Compulsive Disorder lists 30 open slots (35% of 86 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Obsessive - Compulsive Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Obsessive - Compulsive Disorder is recruiting below its size-band peers.
30 of 86 indexed trials (34.9%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Obsessive - Compulsive Disorder trials is spread across many organizations.
Baylor College of Medicine accounts for 7 of 86 trials (8.1%). 45 distinct sponsors appear on at least one study for this condition label.
-
Most Obsessive - Compulsive Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 49 among the 85 trials that report a genuine target (sentinel values excluded). 52 of those (61.2%) plan for fewer than 100 participants.
-
Obsessive - Compulsive Disorder research is mostly interventional.
72 interventional and 14 observational studies make up this index (83.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
86 total, page 2 of 2
Theta Burst Stimulation Plus Habit Override Training for Compulsive Behaviors
Rebecca Price
NCT04580043
Efficacy of Targeted Memory Reactivation for Enhancing Exposure Therapy
University of Texas at Austin
NCT04663672
Cortical Excitability in Obsessive-Compulsive and Related Disorders
National Institute of Mental Health (NIMH)
NCT00029068
Cognitive Behavioral Therapy Plus Drug Treatment for Obsessive Compulsive Disorder
New York State Psychiatric Institute
NCT00045903
Comparing the Effectiveness of Two Family-based Therapies in Treating Young Children With Obsessive-Compulsive Disorder
Rhode Island Hospital
NCT00533806
Treatment of Obsessive Compulsive Disorder in Children
Duke University
NCT00074815
Cognitive Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
University of California, Los Angeles
NCT00748761
Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders
VA Office of Research and Development
NCT01947647
Theta Burst Stimulation for Compulsive Behavior Non-invasive Brain Stimulation Study
University of Pittsburgh
NCT03265015
Treatment of Obsessive-Compulsive Disorder
University of Florida
NCT00000373
Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic
University of Florida
NCT02855580
Cognitive Bias Modification for OCD
Mclean Hospital
NCT03799419
Online Exposure Therapy for Obsessive-Compulsive Disorder (OCD) Study
University of Miami
NCT06470893
Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder
Massachusetts General Hospital
NCT02467374
Assessing the Effects of a Neurobehavioral Intervention on Symptoms of Obsessive Compulsive Disorder
Boston University Charles River Campus
NCT01414023
CBT for Pediatric OCD: Community Training Pilot
Rhode Island Hospital
NCT02202915
Cognitive-Behavioral Treatment for Anxiety Disorders in Children With Autism Spectrum Disorders
University of South Florida
NCT01178385
Methods for Managing Intrusive Thoughts
University of North Carolina, Chapel Hill
NCT03416504
Virtual Reality System to Increase Access to Exposure Therapy for Anxiety and OCD
Mayo Clinic
NCT02713516
Family Based Treatment of Early Childhood Obsessive Compulsive Disorder
Rhode Island Hospital
NCT00055068
Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder
University of South Florida
NCT00632229
Stepped Care for Treating Obsessive-Compulsive Disorder
Hartford Hospital
NCT00316355
Videophone Administered Cognitive-Behavioral Therapy for Pediatric Obsessive-Compulsive Disorder
University of South Florida
NCT00881465
Serotonin Transporters in Obsessive-Compulsive-Related Disorders
National Institute of Mental Health (NIMH)
NCT00082550
Cognitive Behavioral Therapy Plus Motivational Interviewing for Treatment of Obsessive-Compulsive Disorder
New York State Psychiatric Institute
NCT00316316
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
Massachusetts General Hospital
NCT00116532
Randomized Controlled Trial of Standard ERP and OC-Go
University of California, Los Angeles
NCT03601312
Enhancement of Therapeutic Learning in OCD Using tDCS
Yale University
NCT03572543
An Open-Label Study Of Lamictal In Neurotic Excoriation
University of Minnesota
NCT00269594
Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
University of California, Los Angeles
NCT00674219
D-Cycloserine Augmentation to CBT With Exposure and Response Prevention in Adults and Adolescents With OCD
New York State Psychiatric Institute
NCT01172873
Memantine Augmentation in Treatment-Resistant Adults With Obsessive-Compulsive Disorder
New York State Psychiatric Institute
NCT00956085
Personalized Computerized Inhibitory Control Training for OCD
New York State Psychiatric Institute
NCT02378896
Pilot Study of Minocycline (NPL-2003) in Adults With Obsessive-Compulsive Disorder (OCD)
New York State Psychiatric Institute
NCT00728923
TMS for Improving Response Inhibition in Adolescents With OCD
Bradley Hospital
NCT05104697
Treatment of Obsessive-Compulsive Disorder (OCD) in Children
University of Pennsylvania
NCT00000384
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 13 |
| Phase 3 | 6 |
| Phase 4 | 4 |
Top Sponsors
Named interventions
Most-linked intervention names on Obsessive - Compulsive Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Obsessive - Compulsive Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Obsessive - Compulsive Disorder page
86 registered trials, 30 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 30 Obsessive - Compulsive Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Baylor College of Medicine sponsors the most Obsessive - Compulsive Disorder trials on record, review their full trial history before evaluating a specific study. See Baylor College of Medicine's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Obsessive - Compulsive Disorder condition card totals 86 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.